INTEGRA Biosciences to acquire Valdea Biosciences - MarketLine Financial Deals

INTEGRA Biosciences to acquire Valdea Biosciences

INTEGRA Biosciences to acquire Valdea Biosciences - MarketLine Financial Deals
INTEGRA Biosciences to acquire Valdea Biosciences
Published May 21, 2012
2 pages — Published May 21, 2012
Price US$ 20.00  |  Buy this Report Now

About This Report

  
Abstract:

INTEGRA Biosciences AG, a Switzerland-based developer and manufacturer of laboratory instruments, has signed an agreement to acquire Valdea Biosciences SAS.

  
Source:
Document ID
MA111660_120605
Country
Country
Ticker
Private=CH
Format:
PDF Adobe Acrobat
Buy Now

MarketLine Financial Deals—MarketLine Financial Deals – Identifying and tracking major financial activity across our full scope of company and sector coverage, MarketLine Financial Deals covers mergers & acquisitions, private equity/venture capital backed buyouts, investments, and exits, IPOs and secondary and follow on offerings, and private placements and exits. Additional non-corporate financial deals including partnership agreements, joint ventures, co-development and research, licensing and co-marketing agreements are also available.

About the Author


Cite this Report

  
MLA:
MarketLine Financial Deals. "INTEGRA Biosciences to acquire Valdea Biosciences" May 21, 2012. Alacra Store. Dec 04, 2016. <http://www.alacrastore.com/storecontent/MarketLine-Financial-Deals/INTEGRA-Biosciences-to-acquire-Valdea-Biosciences-2052-82773>
  
APA:
MarketLine Financial Deals. (2012). INTEGRA Biosciences to acquire Valdea Biosciences May 21, 2012. New York, NY: Alacra Store. Retrieved Dec 04, 2016 from <http://www.alacrastore.com/storecontent/MarketLine-Financial-Deals/INTEGRA-Biosciences-to-acquire-Valdea-Biosciences-2052-82773>
  
US$ 20.00
$  £  
Have a Question?

Any questions about the report you're considering? Our Customer Service Team can help! Or visit our FAQs.

More Research

Search all our MarketLine Financial Deals from one place.